<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR5">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Choy</surname>
    <given-names>KT</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>AY</given-names>
   </name>
   <name>
    <surname>Kaewpreedee</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Sia</surname>
    <given-names>SF</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>KPY</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>DKW</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>MCW</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>PP</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Peiris</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Yen</surname>
    <given-names>HL</given-names>
   </name>
  </person-group>
  <article-title>Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro</article-title>
  <source>Antiviral Res</source>
  <year>2020</year>
  <volume>178</volume>
  <fpage>104786</fpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104786</pub-id>
  <?supplied-pmid 32251767?>
  <pub-id pub-id-type="pmid">32251767</pub-id>
 </element-citation>
</ref>
